延长俯卧位机械通气治疗COVID-19急性低氧性呼吸衰竭的安全性与结局
42例(68.9%)存活,俯卧位通气总时长为4.87天(2.08-9.97天),前28天中俯卧位时间占30.3%(18.2-42.2%)。延长俯卧位通气在此类患者中可行且相对安全,但仍需关注压力性损伤和神经肌肉并发症。
要点
- 俯卧位通气开始中位时间为插管后0.28天(0.11-0.80天),总俯卧位时长中位4.87天(2.08-9.97天),前28天中占30.3%(18.2-42.2%)。
- 年龄、驱动压、第1天和第3天PaO2:Fio2可预测至死亡时间;除中心线相关血流感染外,医院获得性感染不常见。
适用人群与场景
- 连续机械通气的COVID-19急性呼吸窘迫综合征患者,来自社区学术医疗中心ICU(单中心)。
诊断标准与关键阈值
- 原文未提及明确的俯卧位通气启动标准;仅描述仰卧复位标准:Fio2<60%且PEEP<10 cmH2O持续≥4小时。
- 压力性损伤按Grades 0-4分级评估。
处置流程与药物剂量
- 第一步:实施肺保护性通气。
- 第二步:启动延长俯卧位通气方案,不每日仰卧复位。
- 第三步:仅在Fio2<60%且PEEP<10 cmH2O持续≥4小时时进行仰卧复位。
- 原文未提及具体药物剂量、镇静或肌松方案。
红旗征与不能漏的情况
- 肢体无力(58例,95.1%)和臂丛神经麻痹(5例,8.2%)。
- 原文未提及其他需立刻处理或不能漏诊的红旗征。
研究设计与关键结果
- 年龄、驱动压、第1天和第3天PaO2:Fio2预测至死亡时间;除CLABSI外医院获得性感染不常见。
证据类型、等级与局限
- 证据类型:回顾性单中心研究。
对床旁实践的改变
- 支持在COVID-19 ARDS中采用延长俯卧位通气(不每日仰卧复位),以Fio2<60%且PEEP<10 cmH2O持续≥4小时作为仰卧复位条件。
- 需加强腹侧压力性损伤预防和监测,尤其俯卧位时间长、第3天SOFA评分高的患者。
- 需关注肢体无力和臂丛神经麻痹,原文报告发生率分别为95.1%和8.2%。
- 适用人群:机械通气的COVID-19 ARDS患者;原文未明确不适用人群。
- 常见陷阱:不能将本研究方案剂量或阈值视为通用推荐;原文未提供药物剂量。
指南或共识出处
- Crit Care Med 发表的原始研究:Safety and Outcomes of Prolonged Usual Care Prone Position Mechanical Ventilation to Treat Acute Coronavirus Disease 2019 Hypoxemic Respiratory Failure.
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Prone position ventilation is a potentially life-saving ancillary intervention but is not widely adopted for coronavirus disease 2019 or acute respiratory distress syndrome from other causes. Implementation of lung-protective ventilation including prone positioning for coronavirus disease 2019 acute respiratory distress syndrome is limited by isolation precautions and personal protective equipment scarcity. We sought to determine the safety and associated clinical outcomes for coronavirus disease 2019 acute respiratory distress syndrome treated with prolonged prone position ventilation without daily repositioning.
DESIGN: Retrospective single-center study.
SETTING: Community academic medical ICU.
PATIENTS: Sequential mechanically ventilated patients with coronavirus disease 2019 acute respiratory distress syndrome.
INTERVENTIONS: Lung-protective ventilation and prolonged protocolized prone position ventilation without daily supine repositioning. Supine repositioning was performed only when Fio2 less than 60% with positive end-expiratory pressure less than 10 cm H2O for greater than or equal to 4 hours.
MEASUREMENTS AND MAIN RESULTS: Primary safety outcome: proportion with pressure wounds by Grades (0-4). Secondary outcomes: hospital survival, length of stay, rates of facial and limb edema, hospital-acquired infections, device displacement, and measures of lung mechanics and oxygenation. Eighty-seven coronavirus disease 2019 patients were mechanically ventilated. Sixty-one were treated with prone position ventilation, whereas 26 did not meet criteria. Forty-two survived (68.9%). Median (interquartile range) time from intubation to prone position ventilation was 0.28 d (0.11-0.80 d). Total prone position ventilation duration was 4.87 d (2.08-9.97 d). Prone position ventilation was applied for 30.3% (18.2-42.2%) of the first 28 days. Pao2:Fio2 diverged significantly by day 3 between survivors 147 (108-164) and nonsurvivors 107 (85-146), mean difference -9.632 (95% CI, -48.3 to 0.0; p = 0·05). Age, driving pressure, day 1, and day 3 Pao2:Fio2 were predictive of time to death. Thirty-eight (71.7%) developed ventral pressure wounds that were associated with prone position ventilation duration and day 3 Sequential Organ Failure Assessment. Limb weakness occurred in 58 (95.1%) with brachial plexus palsies in five (8.2%). Hospital-acquired infections other than central line-associated blood stream infections were infrequent.
CONCLUSIONS: Prolonged prone position ventilation was feasible and relatively safe with implications for wider adoption in treating critically ill coronavirus disease 2019 patients and acute respiratory distress syndrome of other etiologies.
参考来源
- Douglas IS, Rosenthal CA, Swanson DD, et al. Safety and Outcomes of Prolonged Usual Care Prone Position Mechanical Ventilation to Treat Acute Coronavirus Disease 2019 Hypoxemic Respiratory Failure. Crit Care Med. 2021. PMID: 33405409. doi:10.1097/CCM.0000000000004818
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。